1. Meyer M, Holfter A, Ruebsteck E, Gruell H, Dewald F, Walter R, Klein F, Lehmann C, Huenseler C, Weber LT. The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany. Viruses. 2021. https://doi.org/10.3390/v13081600
2. World Health Organization. Covid 19 new variants.2021.https://www.who.int/indonesia/news/novel-coronavirus/new-infographics/covid-19-new-variants
3. Center for Disease Control and Prevention (CDC). Understanding Variants. 2021.https://www.cdc.gov/coronavirus/2019-ncov/variants/understanding-variants.html
4. World Health Organization. Tracking SARS-CoV-2 variants.2021 https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
5. Robert Koch Institute. Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute. 2020 https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Dez_2020/2020-12-26-en.pdf?__blob=publicationFile.
6. UNICEF. What you need to know about the Delta variant: Learn how to keep yourself and your family safe from the Delta variant of COVID-19. 2021 https://www.unicef.org/coronavirus/what-you-need-know-about-delta-variant
7. Melissa Jenko. CDC: Delta variant causing increase in pediatric COVID-19 cases, not severity. 2021. AAP News. https://publications.aap.org/aapnews/news/15615/CDC-Delta-variant-causing-increase-in-pediatric
8. Somekh I, Stein M, Karakis I, Simões EA, Somekh E. Characteristics of SARS-CoV-2 Infections in Israeli Children During the Circulation of Different SARS-CoV-2 Variants. JAMA Network Open. 2021;4(9):e2124343. doi:10.1001/jamanetworkopen.2021.24343
9. Nipunie Rajapakse & Devika Dixit (2021) Human and novel coronavirus infections in children: a review, Paediatrics and International Child Health, 41:1, 36-55, DOI: 10.1080/20469047.2020.1781356
10. Brookman S, Cook J, Zucherman M, Broughton S, Harman K, Gupta A. Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people. Lancet Child Adolesc Health. 2021;5(4):e9-e10. doi:10.1016/S2352-4642(21)00030-4
11. U.S. Food and Drug Administration. 2021. FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age